Autoimmune disorders caused by intravesical bacillus Calmette-Guerine treatment: A systemic review.

[1]  A. Masson-Lecomte,et al.  European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). , 2021, European urology.

[2]  A. Miyajima,et al.  Effectiveness of Steroid Pulse Therapy for Systemic Side Effects after Bacillus Calmette-Guérin Intravesical Instillation Therapy: A Series of Five Cases , 2021, Case reports in urology.

[3]  M. Zor,et al.  Uncommon adverse events of intravesical Bacillus Calmette-Guérin treatment: A report of three cases , 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[4]  S. Kocak,et al.  Bacillus Calmette–Guérin-induced perinuclear antineutrophil cytoplasmic antibodies associated vasculitis in bladder cancer , 2021, Journal of cancer research and therapeutics.

[5]  H. Tsuchiya,et al.  Intestinal ulcers induced by intravesical bacillus Calmette-Guérin therapy , 2021, Modern rheumatology case reports.

[6]  C. Locht,et al.  Good old BCG – what a century‐old vaccine can contribute to modern medicine , 2020, Journal of internal medicine.

[7]  I. Grunwald,et al.  Progressive Cerebral Small Vessel Disease Caused by an Autoimmune Response to Intravesical Bacille-Calmette-Guérin Treatment , 2020, Frontiers in Neurology.

[8]  Y. Lotan,et al.  Value of tumour‐infiltrating immune cells in predicting response to intravesical BCG in patients with non‐muscle‐invasive bladder cancer: a systematic review and meta‐analysis , 2020, BJU international.

[9]  J. J. Panisello Sebastiá,et al.  [Unusual evolution of reactive arthritis after endovesical immunotherapy with BCG]. , 2020, Anales del sistema sanitario de Navarra.

[10]  L. Joosten,et al.  Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer , 2020, Nature Reviews Urology.

[11]  D. Lee,et al.  Clinical and molecular insights into BCG immunotherapy for melanoma , 2020, Journal of internal medicine.

[12]  G. D. da Silva,et al.  Reactive Arthritis – A Rare Complication of Intravesical BCG Instillation , 2020, European journal of case reports in internal medicine.

[13]  C. Manzo.  Polymyalgia rheumatica and remitting seronegative symmetrical synovitis with pitting edema following intravesical instillation of bacillus Calmette-Guerin , 2019, Reumatologia.

[14]  Hiroyuki Suzuki,et al.  Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes , 2019, Case Reports in Oncology.

[15]  R. Dhahri,et al.  Unusual evolution of reactive arthritis induced by BCG therapy. , 2019, Therapie.

[16]  H. Kushlaf,et al.  New onset of seropositive generalized myasthenia gravis following intravesical bacille Calmette‐Guerin treatment for bladder cancer: A case study , 2018, Muscle & nerve.

[17]  N. Murray,et al.  Transitory Spontaneous Remission of Myelodysplasia in an Elderly Man while Receiving Intravesical Bacillus Calmette-Guérin for Bladder Cancer: A Case Report and Review of the Literature , 2018, Case reports in hematology.

[18]  H. Yaegashi,et al.  Reiter’s syndrome following intravesical Bacillus Calmette-Guerin therapy for bladder carcinoma: a report of five cases , 2018, International Cancer Conference Journal.

[19]  Hiroaki Nakamura,et al.  Ultrasonographic findings in a patient with reactive arthritis induced by intravesical BCG therapy for bladder cancer , 2018, Journal of Medical Ultrasonics.

[20]  E. Erken,et al.  A Rare Side Effect of Intravesical Bacillus Calmette-Guérin Therapy: Reactive Arthritis , 2018 .

[21]  L. Joosten,et al.  The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders , 2018, Front. Immunol..

[22]  R. Hamilton,et al.  Case: Bacillus Calmette-Guerin (BCG)-induced Reiter syndrome with an attempt at repeat BCG induction. , 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[23]  Rania Kheder-Elfekih,et al.  A case of renal granulomatosis with polyangiitis following intravesical bacillus Calmette-Guérin therapy. , 2018, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[24]  Shigeaki Suzuki,et al.  New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin , 2017, Medicine.

[25]  T. Murez,et al.  [Systemic Bacillus Calmette-Guerin sepsis manifesting as autoimmunity, 17 months after an intravesical BCG-therapy]. , 2017, Medecine et maladies infectieuses.

[26]  Hellen Yuki Umemura Ribeiro,et al.  Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report , 2017, BMC Research Notes.

[27]  M. Yılmaz,et al.  SP082P-ANCA (POSITIVE)VASCULITIS FOLLOWING INTRAVESICAL INSTILLATION OF BACILLUS CALMETTE-GUERIN , 2017 .

[28]  K. Ng,et al.  Reiter's syndrome postintravesical Bacillus Calmette-Guérin instillations. , 2017, Asian journal of surgery.

[29]  H. Miyakawa,et al.  Henoch Schönlein Purpura Nephritis Associated with Intravesical Bacillus Calmette-Guerin (BCG) Therapy , 2017, Internal medicine.

[30]  T. Yoshikawa,et al.  [Reactive Arthritis during the Second Course of Intravesical BCG Therapy Requiring Administration of Methotrexate : A Case Report]. , 2017, Hinyokika kiyo. Acta urologica Japonica.

[31]  E. Bruscia,et al.  Cellular Innate Immunity: An Old Game with New Players , 2016, Journal of Innate Immunity.

[32]  M. Oosting,et al.  Immunometabolic Pathways in BCG-Induced Trained Immunity , 2016, Cell reports.

[33]  R. Xavier,et al.  Trained immunity: A program of innate immune memory in health and disease , 2016, Science.

[34]  L. Joosten,et al.  Long‐term in vitro and in vivo effects of γ‐irradiated BCG on innate and adaptive immunity , 2015, Journal of leukocyte biology.

[35]  K. Akakura,et al.  [REITER'S SYNDROME FOLLOWING INTRAVASICAL BCG THERAPY FOR UROTHELIAL CARCINOMA. SUMMARY OF CASE REPORTS OVER THE PAST 13 YEARS IN JAPAN, INCLUDING OUR CURRENT 6 CASES]. , 2015, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[36]  M. Parafita,et al.  Bilateral Iritis after Vaccine for Bladder Cancer , 2015, Optometry and vision science : official publication of the American Academy of Optometry.

[37]  I. Padjen,et al.  Arthritis After Intravesical Instillation of Bacillus Calmette-Guerin: A Patient With an Unusually Severe Clinical Course Treated With A Combined Anti-Inflammatory and Antimycobacterial Regimen. , 2015, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[38]  G. Velasco,et al.  Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death. , 2015, The Journal of investigative dermatology.

[39]  J. Correa,et al.  Reactive arthritis following Bacillus Calmette-Guérin immunotherapy , 2014 .

[40]  L. Kiemeney,et al.  Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer , 2014, PLoS pathogens.

[41]  S. Cugati,et al.  Ocular involvement following Bacillus Calmette‐Guerin immunotherapy for bladder carcinoma , 2014, Clinical & experimental ophthalmology.

[42]  A. Fazaa,et al.  Reactive arthritis induced by intravesical BCG therapy for bladder cancer , 2014, BMJ Case Reports.

[43]  M. Sebastiani,et al.  Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature. , 2013, Autoimmunity reviews.

[44]  B. Ryffel,et al.  Relative contribution of IL-1α, IL-1β and TNF to the host response to Mycobacterium tuberculosis and attenuated M. bovis BCG , 2013, Immunity, inflammation and disease.

[45]  W. See,et al.  HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guérin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guérin. , 2013, The Journal of urology.

[46]  N. Mori,et al.  [Incomplete Reiter syndrome caused by BCG instillation : a case report]. , 2013, Hinyokika kiyo. Acta urologica Japonica.

[47]  J. Travers,et al.  Worsening of bullous pemphigoid following bacillus Calmette-Guérin treatment for bladder cancer. , 2013, JAMA dermatology.

[48]  H. Bonilla,et al.  Rheumatoid Arthritis, Vasculitis, and Mononeuritis Multiplex After BCG Used in a Patient With Bladder Carcinoma: Case Report and Review of the Literature , 2012 .

[49]  W. A. S. Giraldo,et al.  Artritis reactiva secundaria a la instilación intravesical de bacilo de Calmette-Guérin , 2012 .

[50]  C. Tsao,et al.  New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette–Guerin , 2012 .

[51]  C. Inderjeeth,et al.  Response to treatment with tocilizumab of reactive arthritis induced by intravesical bacillus Galmette‐Guérin unresponsive to DMARDs , 2012, International journal of rheumatic diseases.

[52]  K. Sarkar,et al.  Bilateral symmetrical corneal melting following intravesical Bacille Calmette-Guerin therapy for bladder carcinoma , 2012, Oman journal of ophthalmology.

[53]  Y. Satoh,et al.  Bilateral orbital inflammation following intravesical bacille Calmette–Guérin immunotherapy for bladder cancer , 2012, Japanese Journal of Ophthalmology.

[54]  I. Loukil,et al.  [Unilateral panuveitis following intravesical therapy with bacille of Calmette et Guerin]. , 2012, Bulletin de la Societe belge d'ophtalmologie.

[55]  M. Tappin,et al.  Bilateral Panuveitis following Intravesical BCG Immunotherapy for Bladder Carcinoma , 2010, Ocular immunology and inflammation.

[56]  T. Kawaguchi,et al.  [Reiter's syndrome following intravesical instillation of Bacillus Calmette-Guerin]. , 2010, Hinyokika kiyo. Acta urologica Japonica.

[57]  I. Marie,et al.  [Acute reactive arthritis after intravesical instillation of bacillus Calmette-Guérin. Two case reports and literature review]. , 2010, La Revue de medecine interne.

[58]  G. Wildner,et al.  Uveitis in a patient treated with Bacille-Calmette-Guérin: possible antigenic mimicry of mycobacterial and retinal antigens. , 2009, Ophthalmology.

[59]  Min-Nung Huang,et al.  Self heat-shock protein 65-mediated regulation of autoimmune arthritis. , 2009, Journal of autoimmunity.

[60]  D. Sheehan,et al.  New-onset psoriasis and psoriatic arthritis in a patient treated with Bacillus Calmette-Guérin (BCG) immunotherapy. , 2008, Journal of drugs in dermatology : JDD.

[61]  J. García-Guerrero,et al.  [A seventy-four-year-old man with bilateral conjunctival hyperemia, urinary symptoms, and secondary reactive arthritis following the administration of the BCG vaccine]. , 2008, Gaceta medica de Mexico.

[62]  D. Klionsky,et al.  Autophagosome formation: core machinery and adaptations , 2007, Nature Cell Biology.

[63]  S. Brandau,et al.  Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[64]  A. Prakash,et al.  Nephrotic Syndrome as a Complication of Intravesical BCG Treatment of Transitional Cell Carcinoma of Urinary Bladder , 2007, Renal failure.

[65]  J. R. Zuazu,et al.  Poliartritis secundaria a instilaciones intravesicales de BCG: a propósito de un caso , 2007 .

[66]  C. Ferri,et al.  [Dactilitis and oligoarthritis after BCG immunotherapy in a patient affected by bladder cancer]. , 2011, Reumatismo.

[67]  M. Tektonidou.  Reiter’s syndrome during intravesical BCG therapy for bladder carcinoma , 2007, Clinical Rheumatology.

[68]  S. Mountantonakis,et al.  Acute polyarthritis after bacilli Calmette-Guerin intravesical therapy for bladder carcinoma. , 2006, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[69]  S. Kennedy,et al.  Acute granulomatous tubulointerstitial nephritis caused by intravesical BCG. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[70]  P. H. García,et al.  Artritis reactiva secundaria a inmunoterapia intravesical con bacilo de Calmette-Guerin , 2006 .

[71]  I. Durieu,et al.  [Panuveitis following intravesical bacille Calmette-Guerin therapy]. , 2006, Journal francais d'ophtalmologie.

[72]  V. Ficarra,et al.  Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review , 2006, Rheumatology International.

[73]  B. Mazières,et al.  Remitting seronegative symmetrical synovitis pitting oedema after BCG instillation , 2006, Clinical Rheumatology.

[74]  C. Thirkill,et al.  Autoimmune retinopathy associated with intravesical BCG therapy , 2005, British Journal of Ophthalmology.

[75]  J. Hernández,et al.  Henoch-Schönlein purpura after intravesical administration of bacillus Calmette-Guérin , 2005, Scandinavian journal of infectious diseases.

[76]  P. Morange,et al.  Cryoglobulinemia vasculitis following intravesical instillations of bacillus Calmette-Guerin. , 2004, Clinical and experimental rheumatology.

[77]  N. Sano,et al.  [Polyarthritis caused by intravesical Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer]. , 2004, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[78]  T. Uchida,et al.  [Arthritis following intravesical instillation of BCG for urothelial cancers]. , 2004, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[79]  L. Espinoza,et al.  HLA-B27-Associated Reactive Arthritis: Pathogenetic and Clinical Considerations , 2004, Clinical Microbiology Reviews.

[80]  H. Akaza,et al.  Reiter’s syndrome following intravesical bacille biliÉ de Calmette–GuÉrin treatment for superficial bladder carcinoma: report of six cases , 2004, Modern rheumatology.

[81]  T. Fujii,et al.  [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report]. , 2003, Hinyokika kiyo. Acta urologica Japonica.

[82]  J. Narváez,et al.  Sjögren's-like syndrome following intravesical bacillus Calmette-Guérin immunotherapy. , 2003, The American journal of medicine.

[83]  J. M. Pego,et al.  [Relapsing Reiter's syndrome after Bacillus Calmette-Guérin immunotherapy for bladder carcinoma]. , 2003, Medicina clinica.

[84]  J. Lam,et al.  Bacillus Calmete-Guérin plus interferon-alpha2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity. , 2003, Urologic oncology.

[85]  L. Zografos,et al.  Chorioretinitis Induced by Intravesical Bacillus Calmette-Guérin (BCG) Instillations for Urinary Bladder Carcinoma , 2003, Klinische Monatsblatter fur Augenheilkunde.

[86]  A. Papatsoris,et al.  Two Cases of Acute Polyarthritis Secondary to Intravesical BCG Adjuvant Therapy for Superficial Bladder Cancer , 2002, Clinical Rheumatology.

[87]  M. López-Hoyos,et al.  Reactive arthritis after BCG immunotherapy: T cell analysis in peripheral blood and synovial fluid. , 2002, Rheumatology.

[88]  P. Knoflach,et al.  Protrahierter Verlauf einer Bacillus-Calmette-Guérin-induzierten reaktiven Arthritis , 2002 .

[89]  N. Astbury,et al.  Bilateral uveitis after intravesical BCG immunotherapy for bladder carcinoma , 2002, The British journal of ophthalmology.

[90]  M. Romera,et al.  Articular manifestations after the administration of intravesical BCG. , 2002, Joint, bone, spine : revue du rhumatisme.

[91]  A. Morales,et al.  Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. 1976. , 2002, The Journal of urology.

[92]  F. Berenbaum,et al.  Remitting seronegative symmetrical synovitis with pitting edema following intravesical bacillus Calmette-Guérin instillation. , 2001, The Journal of rheumatology.

[93]  M. Ehrenfeld,et al.  Bcg and autoimmunity: another two-edged sword. , 2001, Journal of autoimmunity.

[94]  S. M. Tariq,et al.  Reiter's syndrome following intravesical BCG immunotherapy , 2000, Postgraduate medical journal.

[95]  D. Lamm.  Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[96]  D. Olchovsky,et al.  Reiter's syndrome after intravesical Bacillus Calmette-Guérin therapy for bladder cancer. , 2000, The Israel Medical Association journal : IMAJ.

[97]  M. Lerch,et al.  Systemic granulomatous disease after intravesical BCG instillation , 2000, BMJ : British Medical Journal.

[98]  A. Böhle.  BCG’s Mechanism of Action – Increasing our Understanding , 1999, European Urology.

[99]  H. Zeidler,et al.  Reactive or infectious arthritis , 1999, Annals of the rheumatic diseases.

[100]  H. Lindsley,et al.  Bacillus Calmette-Guérin associated arthropathy mimicking undifferentiated spondyloarthropathy. , 1999, The Journal of rheumatology.

[101]  F. Grados,et al.  Polyarthritis following intravesical BCG immunotherapy. Report of a case and review of 26 cases in the literature. , 1999, Revue du rhumatisme.

[102]  J. Maillefert,et al.  Refractory arthropathy after intravesical bacillus Calmette-Guérin therapy. Usefulness of isoniazide. , 1999, Revue du rhumatisme.

[103]  L. Resel Folkersma,et al.  [Reiter syndrome: atypical complication of treatment with BCG]. , 1999, Archivos espanoles de urologia.

[104]  Iu M Zakhmatov,et al.  [Polyarthritis as a rare complication in BCG immunoprophylaxis of urinary bladder cancer]. , 1999, Urologiia.

[105]  P. Miossec,et al.  Severe uveitis followed by reactive arthritis after bacillus Calmette-Guérin therapy. , 1999, The Journal of rheumatology.

[106]  R. Çeliker,et al.  Polyarthritis as a Complication of Intravesical Bacillus Calmette–Guerin Immunotherapy for Bladder Cancer , 1999, Clinical Rheumatology.

[107]  F. Lucht,et al.  [Acute oligo-arthritis in a patient treated with BCG therapy for bladder carcinoma]. , 1998, Presse medicale.

[108]  F. Retornaz,et al.  Cryoglobulinemia after intravesical administration of Bacille Calmette-Guérin. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[109]  C. Hansen,et al.  Epididymo-orchitis and Reiter's disease. Two infrequent complications after intravesical bacillus Calmette-Guérin therapy. , 1997, Scandinavian journal of urology and nephrology.

[110]  M. Ahern,et al.  Synovial membrane cytokine profiles in reactive arthritis secondary to intravesical bacillus Calmette-Guérin therapy. , 1997, The Journal of rheumatology.

[111]  B. Kuran,et al.  Reiter syndrome following intracavitary BCG administration. , 1997, Scandinavian journal of urology and nephrology.

[112]  A. Faxvaag,et al.  [Arthritis after BCG treatment of bladder cancer. A rare complication]. , 1996, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[113]  P. Miossec.  Reactive arthritis associated with bacillus Calmette-Guérin immunotherapy for carcinoma of the bladder: immune reactivity against mycobacterial antigens. , 1996, The Journal of rheumatology.

[114]  R. Morgan,et al.  Acute reactive polyarthritis after intravesical bacillus Calmette-Guèrin instillation. , 1995, British journal of urology.

[115]  R. Queiró,et al.  Psoriatic arthropathy after BCG immunotherapy for bladder carcinoma. , 1995, British journal of rheumatology.

[116]  B. Sauvezie,et al.  Arthritis and iritis after bacillus Calmette-Guérin therapy. , 1995, The Journal of rheumatology.

[117]  X. Chevalier,et al.  Acute polyarthritis after BCG-therapy for bladder carcinoma in a patient with ankylosing spondylitis. , 1995, Revue du rhumatisme.

[118]  A. Deodhar,et al.  Arthritis as a complication of intravesical BCG vaccine , 1994, BMJ.

[119]  A. Lin-Greenberg,et al.  Polyarthritis in an elderly man with bladder cancer. , 1994, Hospital practice.

[120]  P. Goupille,et al.  Three cases of arthritis after BCG therapy for bladder cancer. , 1994, Clinical and experimental rheumatology.

[121]  G. Price.  Arthritis and iritis after BCG therapy for bladder cancer. , 1994, The Journal of rheumatology.

[122]  G. Nesher.  [Reiter syndrome after intravesical BCG therapy]. , 1993, Revue du rhumatisme.

[123]  H. Ott,et al.  Reiter's syndrome after intravesical Bacillus Calmette-Guérin treatment for superficial bladder carcinoma. , 1993, British journal of rheumatology.

[124]  D. Henderson,et al.  Reactive arthritis associated with Bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: a report of two cases. , 1993, British journal of rheumatology.

[125]  Y. Chrétien,et al.  Reactive polyarthritis induced by intravesical BCG therapy for carcinoma of the bladder. , 1993, The European journal of medicine.

[126]  S. Faus,et al.  Reiter's syndrome after administration of intravesical bacille Calmette-Guérin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[127]  T. Appelboom,et al.  [Polyarthritis in 4 patients treated with intravesical BCG-therapy for carcinoma of the bladder]. , 1993, Revue du rhumatisme.

[128]  A. Ortí,et al.  [Intravesical BCG and arthritis]. , 1993, Medicina clinica.

[129]  D. Soutif,et al.  Arthritis after Calmette-Guerin bacillus immunotherapy for bladder cancer. , 1992, The Journal of rheumatology.

[130]  D. Puett,et al.  Arthritis after Bacillus Calmette-Guerin Therapy , 1992, Annals of Internal Medicine.

[131]  J. Smyth,et al.  Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. , 1992, The Journal of urology.

[132]  W. Caselmann,et al.  Arthritis after Mycobacterium bovis immunotherapy for bladder cancer. , 1990, Annals of internal medicine.

[133]  R. Hughes,et al.  Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder. , 1989, Annals of the rheumatic diseases.

[134]  D. Lamm,et al.  Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. , 1986, The Journal of urology.

[135]  D. Morton,et al.  Immunological Factors in Human Sarcomas and Melanomas: A Rational Basis for Immunotherapy , 1970, Annals of surgery.